Dysbindin-1 and NRG-1 gene expression in immortalized lymphocytes from patients with schizophrenia

Journal of Human Genetics

Volumn 56, Issue 7, 2011, Pages 478-483

  Yamamori, Hidenaga ^a   Hashimoto, Ryota ^a,b   Verrall, Louise ^a   Yasuda, Yuka ^a   Ohi, Kazutaka ^a   Fukumoto, Motoyuki ^a   Umeda Yano, Satomi ^a   Ito, Akira ^a   Takeda, Masatoshi ^a  

^a OSAKA UNIVERSITY   (Japan)

^b Molecular Research Center for Children's Mental Development   (Japan)

Author keywords

dysbindin 1; gene expression; immortalized lymphocytes; NRG 1; schizophrenia

Indexed keywords

MESSENGER RNA; RNA;

ADULT; ARTICLE; AUTOPSY; BRAIN TISSUE; CELL IMMORTALIZATION; CLINICAL ARTICLE; CONTROLLED STUDY; DYSBINDIN 1 GENE; FEMALE; GENE; GENE EXPRESSION PROFILING; GNAO1 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; LYMPHOCYTE; MALE; MICROARRAY ANALYSIS; NERVOUS TISSUE; NPY1R GENE; NRG 1 GENE; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA;

ADULT; CARRIER PROTEINS; FEMALE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; NEUREGULIN-1; RNA, MESSENGER; SCHIZOPHRENIA;

EID: 79960764813     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2011.40     Document Type: Article

References (32)

1. Gill, M., Donohoe, G. & Corvin, A. What have the genomics ever done for the psychoses? Psychol. Med. 40, 529-540 (2010).
2. Hashimoto, R., Noguchi, H., Hori, H., Ohi, K., Yasuda, Y., Takeda, M. et al. Association between the dysbindin gene (DTNBP1) and cognitive functions in Japanese subjects. Psychiatry Clin. Neurosci. 63, 550-556 (2009).
3. Hashimoto, R., Noguchi, H., Hori, H., Nakabayashi, T., Suzuki, T., Iwata, N. et al. A genetic variation in the dysbindin gene (DTNBP1) is associated with memory performance in healthy controls. World J. Biol. Psychiatry 11, 431-438 (2010).
4. Burdick, K. E., Lencz, T., Funke, B., Finn, C. T., Szeszko, P. R., Kane, J. M. et al. Genetic variation in DTNBP1 influences general cognitive ability. Hum. Mol. Genet. 15, 1563-1568 (2006). (Pubitemid 43904822)
5. Murotani, T., Ishizuka, T., Hattori, S., Hashimoto, R., Matsuzaki, S. & Yamatodani, A. High dopamine turnover in the brains of Sandy mice. Neurosci. Lett. 421, 47-51 (2007). (Pubitemid 46899330)
6. Hattori, S., Murotani, T., Matsuzaki, S., Ishizuka, T., Kumamoto, N., Takeda, M. et al. Behavioral abnormalities and dopamine reductions in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Biochem. Biophys. Res. Commun. 373, 298-302 (2008).
7. Takao, K., Toyama, K., Nakanishi, K., Hattori, S., Takamura, H., Takeda, M. et al. Impaired long-term memory retention and working memory in sdy mutant mice with a deletion in Dtnbp1, a susceptibility gene for schizophrenia. Mol. Brain 1, 11 (2008).
8. McIntosh, A. M., Moorhead, T. W., Job, D., Lymer, G. K., Munoz Maniega, S., McKirdy, J. et al. The effects of a neuregulin 1 variant on white matter density and integrity. Mol. Psychiatry 13, 1054-1059 (2008).
9. Stefansson, H., Sigurdsson, E., Steinthorsdottir, V., Bjornsdottir, S., Sigmundsson, T., Ghosh, S. et al. Neuregulin 1 and susceptibility to schizophrenia. Am. J. Hum. Genet. 71, 877-892 (2002). (Pubitemid 135750519)
10. Falls, D. L. Neuregulins and the neuromuscular system: 10 years of answers and questions. J. Neurocytol. 32, 619-647 (2003). (Pubitemid 39011250)
11. Steinthorsdottir, V., Stefansson, H., Ghosh, S., Birgisdottir, B., Bjornsdottir, S., Fasquel, A. C. et al. Multiple novel transcription initiation sites for NRG1. Gene 342, 97-105 (2004). (Pubitemid 39457182)
12. Hashimoto, R., Straub, R. E., Weickert, C. S., Hyde, T. M., Kleinman, J. E. & Weinberger, D. R. Expression analysis of neuregulin-1 in the dorsolateral prefrontal cortex in schizophrenia. Mol. Psychiatry 9, 299-307 (2004). (Pubitemid 38496722)
13. Deakin, I. H., Law, A. J., Oliver, P. L., Schwab, M. H., Nave, K. A., Harrison, P. J. et al. Behavioural characterization of neuregulin 1 type I overexpressing transgenic mice. Neuroreport 20, 1523-1528 (2009).
14. Talbot, K., Eidem, W. L., Tinsley, C. L., Benson, M. A., Thompson, E. W., Smith, R. J. et al. Dysbindin-1 is reduced in intrinsic, glutamatergic terminals of the hippocampal formation in schizophrenia. J. Clin. Invest. 113, 1353-1363 (2004). (Pubitemid 39069934)
15. Weickert, C. S., Straub, R. E., McClintock, B. W., Matsumoto, M., Hashimoto, R., Hyde, T. M. et al. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch. Gen. Psychiatry 61, 544-555 (2004). (Pubitemid 38747309)
16. Law, A. J., Lipska, B. K., Weickert, C. S., Hyde, T. M., Straub, R. E., Hashimoto, R. et al. Neuregulin 1 transcripts are differentially expressed in schizophrenia and regulated by 5′ SNPs associated with the disease. Proc. Natl Acad. Sci. USA 103, 6747-6752 (2006).
17. Vawter, M. P., Barrett, T., Cheadle, C., Sokolov, B. P., Wood, W. H. III, Donovan, D. M. et al. Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55, 641-650 (2001). (Pubitemid 32888383)
18. Chung, C., Tallerico, T. & Seeman, P. Schizophrenia hippocampus has elevated expression of chondrex glycoprotein gene. Synapse 50, 29-34 (2003). (Pubitemid 37034110)
19. Hakak, Y., Walker, J. R., Li, C., Wong, W. H., Davis, K. L., Buxbaum, J. D. et al. Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA 98, 4746-4751 (2001). (Pubitemid 32295047)
20. Tkachev, D., Mimmack, M. L., Ryan, M. M., Wayland, M., Freeman, T., Jones, P. B. et al. Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362, 798-805 (2003). (Pubitemid 37093922)
21. Sullivan, P. F., Fan, C. & Perou, C. M. Evaluating the comparability of gene expression in blood and brain. Am. J. Med. Genet. B Neuropsychiatr. Genet. 141B, 261-268 (2006).
22. Hranilovic, D., Stefulj, J., Schwab, S., Borrmann-Hassenbach, M., Albus, M., Jernej, B. et al. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol. Psychiatry 55, 1090-1094 (2004). (Pubitemid 38680561)
23. Maeda, K., Nwulia, E., Chang, J., Balkissoon, R., Ishizuka, K., Chen, H. et al. Differential expression of disrupted-in-schizophrenia (DISC1) in bipolar disorder. Biol. Psychiatry 60, 929-935 (2006). (Pubitemid 44584211)
24. Sun, X., Young, L. T., Wang, J. F., Grof, P., Turecki, G., Rouleau, G. A. et al. Identification of lithium-regulated genes in cultured lymphoblasts of lithium responsive subjects with bipolar disorder. Neuropsychopharmacology 29, 799-804 (2004). (Pubitemid 38402488)
25. Vawter, M. P., Ferran, E., Galke, B., Cooper, K., Bunney, W. E. & Byerley, W. Microarray screening of lymphocyte gene expression differences in a multiplex schizophrenia pedigree. Schizophr. Res. 67, 41-52 (2004). (Pubitemid 38117090)
26. Liu, Y. L., Fann, C. S., Liu, C. M., Chang, C. C., Yang, W. C., Hung, S. I. et al. More evidence supports the association of PPP3CC with schizophrenia. Mol. Psychiatry 12, 966-974 (2007). (Pubitemid 47482692)
27. Matigian, N. A., McCurdy, R. D., Feron, F., Perry, C., Smith, H., Filippich, C. et al. Fibroblast and lymphoblast gene expression profiles in schizophrenia: are non-neural cells informative? PLoS One 3, e2412 (2008).
28. Chagnon, Y. C., Roy, M. A., Bureau, A., Merette, C. & Maziade, M. Differential RNA expression between schizophrenic patients and controls of the dystrobrevin binding protein 1 and neuregulin 1 genes in immortalized lymphocytes. Schizophr. Res. 100, 281-290 (2008).
29. Numakawa, T., Yagasaki, Y., Ishimoto, T., Okada, T., Suzuki, T., Iwata, N. et al. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum. Mol. Genet. 13, 2699-2708 (2004). (Pubitemid 39485418)
30. Hikita, T., Taya, S., Fujino, Y., Taneichi-Kuroda, S., Ohta, K., Tsuboi, D. et al. Proteomic analysis reveals novel binding partners of dysbindin, a schizophrenia-related protein. J. Neurochem. 110, 1567-1574 (2009).
31. Hahn, C. G., Wang, H. Y., Cho, D. S., Talbot, K., Gur, R. E., Berrettini, W. H. et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat. Med. 12, 824-828 (2006). (Pubitemid 44050073)
32. Sei, Y., Ren-Patterson, R., Li, Z., Tunbridge, E. M., Egan, M. F., Kolachana, B. S. et al. Neuregulin1-induced cell migration is impaired in schizophrenia: association with neuregulin1 and catechol-o-methyltransferase gene polymorphisms. Mol. Psychiatry 12, 946-957 (2007). (Pubitemid 47482694)